DC Chemicals Limited
China
Product Name: Casopitant mesylate
Price: $Inquiry/100mg
Purity: 98.0%
Stocking Period: 3 Day
Contact: Tony Cao

414910-30-8

414910-30-8 structure

Name: Casopitant mesylate
Chemical Name: (2R,4S)-4-(4-acetylpiperazin-1-yl)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperidine-1-carboxamide,methanesulfonic acid
CAS Number: 414910-30-8
Molecular Formula: C₃₁H₃₉F₇N₄O₅S
Molecular Weight: 712.71900
Catalog: Signaling Pathways GPCR/G Protein Neurokinin Receptor
Create Date: 2017-07-14 23:48:19
Modify Date: 2024-01-10 17:21:58
Casopitant mesylate (GW679769B) is a potent, selective, brain permeable and orally active neurokinin 1 (NK1) receptor antagonist. Casopitant mesylate is a second in the class of antiemetics that acts to antagonise the emetogenic effect of substance P. Casopitant mesylate is also a substrate and a weak-to-moderate inhibitor of CYP3A4. Casopitant mesylate can be used for chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV)[1][2].

Name	(2R,4S)-4-(4-acetylpiperazin-1-yl)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperidine-1-carboxamide,methanesulfonic acid
Synonyms	Rezonic UNII-7VSV9BL497 (2R,4S)-4-(4-ACETYL-(PIPERAZIN-1-YL))-N-{(1R)-1-[3,5-BIS(TRIFLUORO-METHYL)PHENYL]-ETHYL}-2-(4-FLUORO-2-METHYLPHENYL)-N-METHYL-1-PIPERIDINE-CARBOXAMIDE MONOMETHANE-SULFONATE Zunrisa Casopitant mesylate Casopitant mesylate (USAN)

Description	Casopitant mesylate (GW679769B) is a potent, selective, brain permeable and orally active neurokinin 1 (NK1) receptor antagonist. Casopitant mesylate is a second in the class of antiemetics that acts to antagonise the emetogenic effect of substance P. Casopitant mesylate is also a substrate and a weak-to-moderate inhibitor of CYP3A4. Casopitant mesylate can be used for chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV)[1][2].
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> Cytochrome P450 Signaling Pathways >> Neuronal Signaling >> Neurokinin Receptor Research Areas >> Neurological Disease Signaling Pathways >> GPCR/G Protein >> Neurokinin Receptor
Target	NK1 CYP3A4
In Vivo	In a ferret-model of Cisplatin- induced emesis, Casopitant (GW679769) inhibits retching and vomiting and reduced nausea-like behaviours in a dose-dependent manner. The pharmacokinetics and brain penetration of casopitant are studied in the ferret-model of cisplatin-induced emesis. Following a single intraperitoneal dose, radioactive labeled Casopitant ([14C]Casopitant) is rapidly absorbed, with plasma and brain concentrations being approximately equal at two hours post-dosing. [14C]Casopitant is found in the brain as the parent compound and two major oxidative metabolites (M1 and M2), accounting for approximately 76%, 19%, and 3% of the radioactivity, respectively; suggesting that the pharmacologic activity of Casopitant in the ferret is largely attributable to the parent compound. Casopitant possesses a high affinity for brain NK1 receptors in the ferret[2].
References	[1]. Ruhlmann C, et al. Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting. Ther Clin Risk Manag. 2009 Apr;5(2):375-84. [2]. Minthorn E, et al. Pharmacokinetics and brain penetration of casopitant, a potent and selective neurokinin-1 receptor antagonist, in the ferret. Drug Metab Dispos. 2008 Sep;36(9):1846-52.

Molecular Formula	C₃₁H₃₉F₇N₄O₅S
Molecular Weight	712.71900
Exact Mass	712.25300
PSA	109.85000
LogP	7.05280

414910-30-8	852393-14-7
414910-27-3	2763365-40-6
833482-77-2	202464-88-8
157605-25-9	144143-96-4
98819-77-3	857890-39-2